ABACAVIR SULPHATE LAMIVU
ABACAVIR SULPHATE LAMIVU is a medication manufactured by CIPLA. It falls under the category of Uncategorised medicines. The packing type is a strip of 30 tablets. The actual MRP of the medicine is Rs. 2996.04, but it is being sold at a discounted price of 2275, which amounts to a discount of 24.07%.
Active Ingredients:
The active ingredients in ABACAVIR SULPHATE LAMIVU are abacavir sulfate and lamivudine.
Pharmacological Properties:
ABACAVIR SULPHATE LAMIVU is a combination medication that works by inhibiting the activity of the reverse transcriptase enzyme in the body. This helps in reducing the replication of the HIV virus, thereby slowing down the progression of the disease.
Indications:
ABACAVIR SULPHATE LAMIVU is indicated for the treatment of HIV infection in adults and pediatric patients weighing at least 25 kg.
Contraindications:
ABACAVIR SULPHATE LAMIVU should not be used in patients with a history of hypersensitivity to abacavir or lamivudine. It is also contraindicated in patients with severe hepatic impairment.
Dosage:
The recommended dosage of ABACAVIR SULPHATE LAMIVU is based on the patient’s weight and renal function. It is important to follow the dosage instructions provided by the healthcare provider.
Side Effects:
Common side effects of ABACAVIR SULPHATE LAMIVU may include nausea, vomiting, diarrhea, fatigue, and headache. Serious side effects such as hypersensitivity reactions and lactic acidosis may also occur.
Drug Interactions:
ABACAVIR SULPHATE LAMIVU may interact with other medications such as methadone, sorbitol-containing products, and other antiretroviral drugs. It is important to inform the healthcare provider about all the medications being taken.
Patient Counseling:
Patients taking ABACAVIR SULPHATE LAMIVU should be counseled about the importance of adherence to the prescribed treatment regimen. They should also be educated about the potential side effects and when to seek medical attention.
Clinical Evidence:
Several clinical studies have demonstrated the efficacy and safety of ABACAVIR SULPHATE LAMIVU in the treatment of HIV infection. These studies have shown a reduction in viral load and an improvement in CD4 cell count in patients receiving this medication.
Frequently Asked Questions:
1. Can ABACAVIR SULPHATE LAMIVU cure HIV?
No, ABACAVIR SULPHATE LAMIVU is not a cure for HIV, but it helps in controlling the viral replication and slowing down the progression of the disease.
2. How should I take ABACAVIR SULPHATE LAMIVU?
ABACAVIR SULPHATE LAMIVU should be taken exactly as prescribed by the healthcare provider. It is usually taken orally with or without food.
3. What should I do if I miss a dose of ABACAVIR SULPHATE LAMIVU?
If you miss a dose of ABACAVIR SULPHATE LAMIVU, take it as soon as you remember. However, if it is almost time for the next dose, skip the missed dose and continue with the regular dosing schedule. Do not double the dose to make up for the missed one.
4. What are the signs of a hypersensitivity reaction to ABACAVIR SULPHATE LAMIVU?
Signs of a hypersensitivity reaction may include fever, rash, nausea, vomiting, and abdominal pain. If you experience any of these symptoms, seek medical attention immediately.
5. Can I drink alcohol while taking ABACAVIR SULPHATE LAMIVU?
It is generally recommended to avoid excessive alcohol consumption while taking ABACAVIR SULPHATE LAMIVU as it may increase the risk of certain side effects.
